Literature DB >> 2704999

Current developments and future direction with ifosfamide. Proceedings of a satellite symposium of the European Society of Medical Oncology. October 31, 1988, Lugano, Switzerland.

.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2704999

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  2 in total

1.  Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer.

Authors:  R Paridaens; C Focan; J Michel; M Piccart; E Salamon; M Beauduin; M T Closon; E Tueni; A Vindevoghel; F Majois
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Ifosfamide treatment as a 10-day continuous intravenous infusion.

Authors:  H J Keizer; J Ouwerkerk; K Welvaart; C J van der Velde; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.